Unlocking the secrets of our passion and expertise
Everything you need to know about AHB Lab
Who are we?
A Developing Novel Biosynthetic Peptide Manufacturer
AHB Lab is the Taiwan biotech pioneer company focusing on the devel- opment and supply of novel biosynthetic peptide and their commercialized products with self-developed core technology “Synthetic Biology Peptido- mimetic Platform (SBPP)”. SBPP is completed in mass production process for dipeptides to henicosapeptide with low-cost and high-yield way, aiming at peptide-based therapy relevant in cosmetics, nutraceuticals, medicine. At present, 11 biosynthetic peptide materials and 4 biosynthetic peptide-based series of products have been completed.
The biosynthetic peptides for the treatment of degenerative arthritis, and its medical application has obtained 6 international invention patents from Taiwan, Japan, and China. Broad patent portfolio of 18 patent applications covering 6 key markets will cover new indication of biosynthetic peptide for treatment of degenerative arthritis, tendon fasciitis, ligamentitis, oral muco- sal wound healing, sleep aid, immunity enhancement, prostate mainte- nance, gastroesophageal reflux, intestinal health, diabetes, cardiovascular, liver function, osteoporosis, rheumatoid arthritis, inflammatory storm, anti-aging, anti-tumor, life extension, sexual dysfunction, blood circulation, increase blood oxygen and nitric oxide level, anti-wrinkle, reduce fine lines.
Meet our professional teams that makes everything happen
We are creating tomorrow's solutions today
Chairman / CEO
Tamkang University Ph.D. in Chemistry
National Taiwan University of Science and Technology Bachelor of Materials Science and Engineering
YUN C. YUNG
University of California, SD Ph.D in Biomedical Sciences
Vice President of Overseas Business Department
University of California Master of Public Health